BOB体育

Skip to main content
(352) 733-0111

Nicotine Cessation for Women with Breast Cancer (UF-BRE-013)

  • Status
    Accepting Candidates
  • Age
    18 Years - 80 Years
  • Sexes
    Female
  • Healthy Volunteers
    No
I'm interested
Share this study

Objective

Close to 20% of cancer patients currently use nicotine products. Nicotine use in breast cancer patients is associated with poorer overall outcomes, including worsened survival and increased surgical complications. Nicotine cessation is rarely addressed in breast cancer patients at the time of diagnosis and may be a missed opportunity to optimize patient outcomes. Patients that use nicotine products are not offered reconstruction at time of mastectomy or oncoplastics at the time of lumpectomy, which can be emotionally distressing in women with breast cancer. Reconstruction could be an additional motivating factor in nicotine cessation success.

This study aims to evaluate the feasibility of a nicotine cessation program designed by Area Health Education Center (AHEC) in the target population. The study is designed to test the acceptability, and preliminary efficacy of a formal nicotine cessation program in women actively using nicotine products with breast cancer recommended for reconstructive or oncoplastics surgery.

Details

Full study title Preoperative Nicotine Cessation for Women with Breast Cancer Recommended for Reconstruction
Protocol number OCR44983
ClinicalTrials.gov ID NCT06461650
Phase N/A

Eligibility

Inclusion Criteria:

  • Adults 鈮� 18 years of age and 鈮� 80 years of age.

  • Women who are diagnosed with Stage 0 * 3 breast cancer confirmed by biopsy

  • Women who have been recommended to have reconstruction at time of mastectomy or oncoplastics at time of lumpectomy

  • Participants who actively use nicotine products defined as any self-reported nicotine use within the past month

  • Participant agrees to comply with all the study-related procedures.

Exclusion Criteria:

  • Patients not eligible for reconstruction or oncoplastics for other reasons including BMI>35 or inflammatory breast cancer or based on surgeon discretion.

  • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

  • Patients unable to complete the sessions because of language, travel or technology barriers

  • Patients already actively participating in another cessation program

  • Patients who are pregnant.

Lead researcher

  • Jennifer Fieber, MD
    Cancer Specialist (Oncologist), Surgical Oncologist (Surgical Specialist - Cancer)

Participate in a study

Here are some general steps to consider when participating in a research study:

  1. Step
    1

    Contact the research team

    Call or email the research team listed within the specific clinical trial or study to let them know that you're interested. A member of the research team, such as the researcher or study coordinator, will be available to tell you more about the study and to answer any questions or concerns you may have.

    Primary contact

  2. Step
    2

    Get screened to confirm eligibility

    You may be asked to take part in prescreening to make sure you are eligible for a study. The prescreening process ensures it is safe for you to participate. During the prescreening process, you will be asked some questions and you may also be asked to schedule tests or procedures to confirm your eligibility.

  3. Step
    3

    Provide your consent to participate

    If you are eligible and want to join the clinical trial or study, a member of the research team will ask for your consent to participate. To give consent, you will be asked to read and sign a consent form for the study. This consent form explains the study's purpose, procedures, risks, benefits and provides other important information, such as the study team's contact information.

  4. Step
    4

    Participate

    If you decide to participate in a clinical trial or study, the research team will keep you informed of the study requirements and what you will need to do to throughout the study. For some trials or studies, your health care provider may work with the research team to ensure there are no conflicts with other medications or treatments.